| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $376.8M | +22.5% |
| Cost of Revenue | $65.5M | +25.1% |
| Gross Profit | $311.3M | +21.9% |
| R&D Expense | $80.1M | +39.4% |
| SG&A Expense | $78.6M | +1.6% |
| Operating Income | $8.3M | +208.4% |
| Pre-tax Income | $20.4M | +339.1% |
| Income Tax | $13.0M | +252.5% |
| Net Income | $8.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.9M | -16.9% |
| Accounts Receivable | $9.0M | +13.4% |
| Current Assets | $276.2M | +4.0% |
| Total Assets | $390.9M | +17.9% |
| Current Liabilities | $114.1M | +20.8% |
| Total Liabilities | $124.6M | +16.3% |
| Stockholders' Equity | $256.6M | +17.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $47.0M | +488.5% |
| Capital Expenditures | $3.8M | +52.9% |
| Investing Cash Flow | -$58.2M | -100.3% |
| Financing Cash Flow | $1.9M | +9942.1% |
| Free Cash Flow | $43.2M | +685.3% |
| +766.9% |
| EPS (Basic) | $0.06 | +500.0% |
| EPS (Diluted) | $0.06 | +500.0% |